One study demonstrates that, in male and female patients with mood depressive disorders (MDD), ghrelin administration (50 μg between 11 p.m. and 1 a.m.)induces transient GH and cortisol secretion, increases the time of sleeping in males only but has no significant effect on depressive symptoms (128). The gene discussed is GHRL; the disease is major depressive disorder.